Alexander Falkentoft (@AFalkentoft) profile picture

Alexander Falkentoft

@AFalkentoft

MD, PhD student, interested in cardiology and diabetes.

Joined August 2015
  • Tweets24
  • Following86
  • Followers94
Alexander Falkentoft retweeted
M. El-Chouli (@m_chouli) profile picture
M. El-Chouli@m_chouli29 Aug 2023
Ever wonder about all the non-cardiovascular diseases in #MI patients? Read this amazing paper on temporal trends on non-CV disease in MI patients through 17 years by @DanielMolager and @tsg_sehested in @JACCJournals. #CardioTwitter #NonCardiotwitter
This Post is from an account that no longer exists. Learn more
2
4
10
1,121
Many relevant findings from PhD student @kasperbengtsen in his national study on risk factors associated with early and late S. aureus bacteraemia in CIED pts presented at #ESCCongress 🫀🧫 Congratulations on the hard work!👏👏 #ESC2023 #DCS_ESC23
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
6
4
1
12
1,213
Alexander Falkentoft retweeted
Daniel J Drucker (@DanielJDrucker) profile picture
Daniel J Drucker@DanielJDrucker2 Aug 2023
Beyond glucose control, the opportunity for risk factor management in PPL with new #T2D often remains unfulfilled leading to higher rates of #heartdisease #CVD @Filip_Knop @DiabetologiaJnl link.springer.com/article/10…
Image from Daniel J Drucker (@DanielJDrucker)
2
4
1
19
4,819
Alexander Falkentoft retweeted
Tour de France™ (@LeTour) profile picture
Tour de France™
@LeTour22 Jul 2023
🔁 RT if you think 🇩🇰 @Mads__Pedersen is the Super-combative of the #TDF2023! 🔁 RT si vous pensez que 🇩🇰 @Mads__Pedersen est le Super-combatif du #TDF2023 !
Image from Tour de France™ (@LeTour)
78
3,114
43
2,735
635,641
Alexander Falkentoft retweeted
Jarl Emanuel Strange (@JarlStrange) profile picture
Jarl Emanuel Strange@JarlStrange16 Apr 2023
What is the association between #frailty and time in hospital following #TAVR? Find out in @JAHA_AHA Frail patients have an⬆️risk of death & complications. For these patients, life-expectancy is limited and time in hospital is central for quality of life, yet data remain sparse
2
3
8
635
In this @TheLancet sdy @MariamElmegaard et al found that in 77,745 ptts w first time SGLT2-is and 56,037 GLP1-RAs the risk of discontinuing was 56% and 45%, respectively, w a decreased risk over the sdy-period thelancet.com/journals/lanep… #Cardiotwitter @cardiology @diabetes
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
1
9
25
1,650
Alexander Falkentoft retweeted
Filip K. Knop (@Filip_Knop) profile picture
Filip K. Knop@Filip_Knop21 Mar 2023
Data on all Danish first-time users of SGLT2is and GLP1-RAs from 2013 to 2021 show that ~50% discontinued therapy within five years, but a quarter of these reinitiated therapy during the following year. Discontinuation rates decreasing with time. thelancet.com/journals/lanep…
Cumulative incidence of discontinuation and subsequent reinitiation of therapy. Five-year cumulative incidence of discontinuation (Fig. a and b) and one-year cumulative incidence of reinitiation of therapy (Fig. c and d) with 95% confidence intervals. An initial blanking period of 90 days were computed when analysing the discontinuation, due to the definition as a gap of ≥90 days (Fig. a and b).

ALT Cumulative incidence of discontinuation and subsequent reinitiation of therapy. Five-year cumulative incidence of discontinuation (Fig. a and b) and one-year cumulative incidence of reinitiation of therapy (Fig. c and d) with 95% confidence intervals. An initial blanking period of 90 days were computed when analysing the discontinuation, due to the definition as a gap of ≥90 days (Fig. a and b).

Cumulative incidence of discontinuation of therapy for SGLT2-i users (Fig. a) and GLP1-1 users (Fig. b) by calendar year of initiation. 3-year cumulative incidence of discontinuation of therapy with 95% confidence intervals and with a limit of the y-axis of 60%. An initial blanking period of 90 days were computed when analysing the discontinuation, due to the definition as a gap of ≥90 days.

ALT Cumulative incidence of discontinuation of therapy for SGLT2-i users (Fig. a) and GLP1-1 users (Fig. b) by calendar year of initiation. 3-year cumulative incidence of discontinuation of therapy with 95% confidence intervals and with a limit of the y-axis of 60%. An initial blanking period of 90 days were computed when analysing the discontinuation, due to the definition as a gap of ≥90 days.

1
4
21
1,610
Alexander Falkentoft retweeted
David Laursen (@LaursenDavid) profile picture
David Laursen@LaursenDavid8 Mar 2023
🧵 In our recent #Cochrane Review, we look at the impact of using #ActivePlacebo control versus standard placebo in randomised drug trials. doi.org/10.1002/14651858.MR0… #Blinding #Unblinding #Placebo #Bias @cochranemthds @AsgerPaludan @ChrisPaWer 1/10
4
10
2
31
7,952
In this sdy, @cnsolli et al. found that 1 dose of amoxicillin/clavulanic acid 500/125 mg or clindamycin 600 mg within 30-120 min. prior to hemodialysis was sufficient to maintain prophylactic plasma concentrations throughout the whole duration. 🦠+💊=💀 pubmed.ncbi.nlm.nih.gov/3664…
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
1
2
5
418
Alexander Falkentoft retweeted
M. El-Chouli (@m_chouli) profile picture
M. El-Chouli@m_chouli9 Dec 2022
Just out in @ESC_journals: Simple CHD💔patients faced ⬆️ lifetime risk of comorbidity i.a. #AF #mi #stroke & #heartfailure compared w controls, manifested in ⬆️ age 👴🏼🧓🏼. academic.oup.com/eurheartj/a… #ACHD #CVD #cardiotwitter @escardio @Hjerteforening @CopCard @ehj_ed
Image from M. El-Chouli (@m_chouli)
4
5
2
26
Improved outcomes after MI over time 📈 2️⃣0️⃣0️⃣0️⃣🆚2️⃣0️⃣1️⃣7️⃣ ☠️Mortality, 18.6% to 12.5% 💔Recurrent MI, 7.5% to 5.5% 🩸Bleeding, 3.9% to 2.7% Mortality was as low as 2.6% in 2015–17 for pts <60 years 👀 academic.oup.com/eurheartj/a… #CardioTwitter #Cardiology
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
1
9
21
Alexander Falkentoft retweeted
EHJ Editor-in-Chief (@ehj_ed) profile picture
EHJ Editor-in-Chief
@ehj_ed27 Nov 2022
Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study @escardio @ESC_Journals #CardioTwitter #EHJ #myocardialinfarction academic.oup.com/eurheartj/a…
Image from EHJ Editor-in-Chief (@ehj_ed)
2
47
7
110
Alexander Falkentoft retweeted
Jarl Emanuel Strange (@JarlStrange) profile picture
Jarl Emanuel Strange@JarlStrange16 Nov 2022
Important contribution to the growing field of cardio-oncology. How does cancer type & status impact the prognosis of ACS? What is the cause of death? How are they managed? All important questions addressed by @NinaNouhravesh Find out below! bitly.ws/wKcG
Herlev og Gentofte hosp afd for hjertesygdomme (@HGHHjerte) profile pictureHerlev og Gentofte hosp afd for hjertesygdomme@HGHHjerte16 Nov 2022
Hjerte-kar-sygdomme var den hyppigste dødsårsag hos patienter med aktive og ikke-aktive kræft 🦀 Nyt studie fra @NinaNouhravesh, @MortenLamberts fra @HGHHjerte og kollegaer i @AmericanHeartJ sciencedirect.com/science/ar…
Image from Herlev og Gentofte hosp afd for hjertesygdomme (@HGHHjerte)
Image from Herlev og Gentofte hosp afd for hjertesygdomme (@HGHHjerte)
2
5
11
Cardiovascular disease was the leading cause of death in pts w active- and non-active cancers 🦀 Sdy from @NinaNouhravesh et al in @AmericanHeartJ 👇 sciencedirect.com/science/ar…
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
2
7
25
In this @ESC_Journals #QCCO sdy @PaulineRavn et al found decreasing ⬇️ risk of recurrent #myocardial_infarction, first-time admission 🏥 for #heartfailure and all-cause mortality 💀 in patients with a first-time myocardial infarction 🔗academic.oup.com/ehjqcco/adv…
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
3
7
22
In this #EHJQCCO sdy @DanielMolager et al found influenza vaccine 💉 uptake is suboptimal among ptts w CVD, even w free-of-charge vaccinations 🧬 Vaccine uptake was particularly low among young patients 👦🏼👧🏾🧒🏽 🔗academic.oup.com/ehjqcco/adv… #cardiotwitter #Cardiology
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
1
4
10
This @IJCardio sdy by @cnsolli found that pts w/ myeloproliferative neoplasms in a DK cohort had ⬆️frequency of aortic valve and severe coronary artery calcifications than general pts. bit.ly/3OqxmoY #cardiotwitter #atherosclerosis #dkforsk #hematology #mpn #mpnsm
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
1
2
8
In this @AnnalsofIM sdy @AndersHolt6 et al found that from 2000 to 2018, the use of PDE5 inhibitors🍆 increased 2️⃣0️⃣-fold among ptts with IHD who were taking nitrates No significant increased 🛑of CV events were found in these ptts 🔗bit.ly/3JXT3cX #CardioTwitter
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
1
5
18
2 of our MDs @AnneSchjerning & @tsg_sehested have contributed to this paper by @DanielMolager et al in @ATHjournal who showed 1st time AMI has ⬇️ from 2005-2021 in DK in both sexes + all ages - most in elderly ≥ 70 yrs. 🫀 To continuous improvement!🥳 atherosclerosis-journal.com/…
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
Image from Dept. of Cardiology, Zealand University Hospital (@CardiologyZuh)
2
2
18
In this @SAGEClinMed "Research Methods in Medicine & Health Sciences" paper 📝, P Blanche ,@bochrajamal @pvibe_rasmussen argue that a HR >1️⃣ in time-dependent Cox model 🖥️, an does not necessarily mean that there is a higher risk 🤯 🔗bit.ly/3v5IgJN #Statistics
Image from Copenhagen Cardiovascular Research Center (@CopCard)
Image from Copenhagen Cardiovascular Research Center (@CopCard)
1
6
1
17
Load more